Tirzepatide additionally targets GIP receptors, producing a dual-action effect that may result in greater weight loss for some patients

Several retrospective studies associated the drug class with lower glaucoma risk and reduced ocular hypertension incidence, while preclinical work demonstrated reduced retinal ganglion cell loss and optic nerve damage in experimental models. The experimental literature also points to inflammatory modulation, oxidative stress reduction and retinal ganglion cell survival pathways as possible mechanisms. Smaller studies evaluating IIH and DED reported reductions in intracranial pressure and improved ocular surface parameters, respectively, among treated patients. READ MORE: Blinding Disease-Weight Loss Drug Link: EMA Announces Start of Semaglutide Investigation The evidence base still has limits The review flagged recurring methodological constraints across the literature: reliance on retrospective EHR analyses and ICD-based coding, heterogeneous ocular endpoints, inconsistent imaging and limited longitudinal follow-up

What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition
As it is standard for all robotaxi developers, the initial focus will be on manually mapping the new cities before any autonomous testing takes place
Finally, ongoing research is essential
However, when exposed to external stressors such as hyperglycemia, complex dysfunction can lead to increased levels of this physiological process